Study of Mycamine® in Infants and Toddlers With Fungal Infections to Evaluate Safety and Blood Levels of the Drug

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov Identifier: NCT00607763
Year 2008
PURPOSE: Infants and toddlers with fungal infections will receive 10 to 14 days of treatment with an antifungal drug. Safety and drug blood levels will be assessed.
Epistemonikos ID: 58bc76c0db6c8f7c5cb2350a2bfa982b9ca2506d
First added on: Apr 29, 2015